²é¿´: 1041  |  »Ø¸´: 5

fanjiaojiao

Òø³æ (СÓÐÃûÆø)

[ÇóÖú] Çó´óÉñ°ïæÈóÉ«¼¸¾äÕªÒª£¬Ð¡Å®×ÓÌáǰ¸ÐлÁË~~

ÎÒÓ¢Óï±È½Ï²î£¬Âé·³´óÉñ°ïæÈóɫһÏ£¬½ð±Ò²»¹»¿ÉÒÔ×·¼ÓµÄ£¿ÌáǰO(¡É_¡É)
Results Compared with the control group£¬the number of peripheral white blood cell£¨WBC£©£¬red blood cell£¨RBC£©£¬hemoglobin£¨HGB£©£¬lymphocyte£¨LYMF£©and granulocyte£¨GRAN£©of model group decreased significantly (P < 0.05 or P < 0.01). Furthermore£¬varying degrees of damages in bone marrow megakaryocyte cells were revealed by the smears of bone marrow. Compared with the model group£¬the number of peripheral WBC of drug-treated groups increased significantly£¨P < 0.01£©£¬especially in the group of rhG-CSF of the WBC and GRAN£¨P < 0.01£©.The number of blood cells of guinea pigs in the group with medium dose of Zhengyuan Prescription increased significantly£¨P < 0.01 or P < 0.05£©£¬while the organ indexes of heart£¬liver£¬spleen£¬lung£¬kidney had no significant changes£¨P > 0.05£©. Bone marrow smears showed that Zhengyuan Prescription medium dose group had a better therapeutic effect on the bone marrow nucleated cells and megakaryocytic cells system suppressed by CTX. Conclusion Zhengyuan Prescription could promote the recovery of peripheral blood and regeneration of bone marrow cells of guinea pigs induced by CTX£¬and had a protective effect on the bone marrow hematopoietic system.

ÏÂÃæÊÇÎҵĺºÓï
½á¹û  Óë¶ÔÕÕ×é±È½Ï£¬Ä£ÐÍ×éëàÊóµÄÍâÖÜѪ°×ϸ°û¡¢ºìϸ°û¡¢Ñªºìµ°°×¡¢ÁܰÍϸ°û¡¢Á£Ï¸°û¼ÆÊý¾ù·¢Éú²»Í¬³Ì¶ÈµÄ½µµÍ£¨P < 0.05»òP < 0.01£©£¬¹ÇËèͿƬÏÔʾ¹ÇËè¾ÞºËϸ°ûÊܵ½²»Í¬³Ì¶ÈµÄÆÆ»µ£»ÓëÄ£ÐÍ×é±È½Ï£¬¸÷¸øÒ©×éµÄ°×ϸ°û¼ÆÊý¾ùÏÔÖøÉÏÉý£¨P < 0.01£©£¬ÒÔrhG-CSF×éÌáÉý°×ϸ°û¡¢Á£Ï¸°û¼ÆÊý×îÏÔÖø£¨P < 0.01£©£»ÆäÖÐÕýÔ´·½ÖмÁÁ¿×éµÄ°×ϸ°û¡¢ºìϸ°û¡¢Ñªºìµ°°×¡¢ÁܰÍϸ°û¡¢Á£Ï¸°û¼ÆÊý¾ùÏÔÖøÉÏÉý£¨P < 0.01 »ò P < 0.05£©£»¸÷¸øÒ©×éëàÊóµÄÐÄ¡¢¸Î¡¢Æ¢¡¢·Î¡¢ÉöÖ¸Êý²¢ÎÞÏÔÖø±ä»¯£¨P > 0.05£©£»¹ÇËèͿƬÏÔʾÕýÔ´·½ÖмÁÁ¿×é¶Ô»·Á×õ£°·ÒÖÖÆµÄ¹ÇËèÓкËϸ°ûºÍ¾ÞºËϸ°ûϵͳÐÞ¸´×÷ÓÃ×îºÃ¡£½áÂÛ  ÕýÔ´·½Äܹ»´Ù½ø»·Á×õ£°·ËùÖÂëàÊó¹ÇËèÒÖÖÆÍâÖÜѪµÄ»Ö¸´ºÍ¹ÇËèϸ°ûµÄÔÙÉú£¬¶ÔëàÊóµÄ¹ÇËèÔìѪϵͳÓÐÒ»¶¨µÄ±£»¤×÷Óá£:
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

¼ÓÓÍ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

leilejiayou

ľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
fanjiaojiao: ½ð±Ò+4, ¡ïÓаïÖú, ¸Ðл³æÓÑÈÈÐÄÓ¦Öú~~Ö÷ÒªÊÇÈðɫһÏÂÓ¢ÓºÇºÇ£¬²»¹ý»¹ÊÇллÄã 2013-11-06 11:49:41
hanches: ½ð±Ò+2, ¸ÐлÈÈÐÄÓ¦Öú£¬»¶Ó­³£À´±¾°æ²ÎÓë½»Á÷O(¡É_¡É)O~~~ 2013-11-06 13:47:57
fanjiaojiao: ½ð±Ò+5, ¡ïÓаïÖú, лл 2013-11-06 14:14:34
Â¥Ö÷·­ÒëµÄºÜºÃÁË£¬ÐÞ¸ÄÁËÒ»µãµã£¬¹©²Î¿¼¡£

½«½á¹ûÓë¶ÔÕÕ×é±È½Ï£¬·¢ÏÖÄ£ÐÍ×éëàÊóµÄÍâÖÜѪ°×ϸ°û¡¢ºìϸ°û¡¢Ñªºìµ°°×¡¢ÁܰÍϸ°û¡¢Á£Ï¸°ûÊýÁ¿¾ù·¢Éú²»Í¬³Ì¶ÈµÄ¼õÉÙ£¨P < 0.05»òP < 0.01£©£¬´Ó¹ÇËèͿƬ¿ÉÖª¹ÇËè¾ÞºËϸ°ûÒ²Êܵ½Á˲»Í¬³Ì¶ÈµÄÆÆ»µ¡£ÓëÄ£ÐÍ×é±È½Ï£¬¸÷¸øÒ©×éµÄ°×ϸ°ûÊýÁ¿¾ùÏÔÖøÉÏÉý£¨P < 0.01£©£¬ÒÔrhG-CSF×é°×ϸ°û¡¢Á£Ï¸°ûÊýÁ¿Ôö¼Ó×îΪÏÔÖø£¨P < 0.01£©¡£ÕýÔ´·½ÖмÁÁ¿×éëàÊóѪϸ°ûÊýÏÔ×ÅÔö¼Ó£¨P <0.01»òP <0.05£©£¬¶øÐÄ£¬¸Î£¬Æ¢£¬·Î£¬ÉöÆ÷¹ÙÖ¸±ê¾ùÎÞÏÔ×ű仯£¨P>0.05£©¡£¹ÇËèͿƬÏÔʾÕýÔ´·½ÖмÁÁ¿×é¶Ô»·Á×õ£°·ÒÖÖÆµÄ¹ÇËèÓкËϸ°ûºÍ¾ÞºËϸ°ûϵͳÐÞ¸´×÷ÓÃ×îºÃ¡£½áÂÛ£ºÕýÔ´·½Äܹ»´Ù½ø»·Á×õ£°·ËùÖÂëàÊó¹ÇËèÒÖÖÆÍâÖÜѪµÄ»Ö¸´ºÍ¹ÇËèϸ°ûµÄÔÙÉú£¬ÇÒ¶ÔëàÊóµÄ¹ÇËèÔìѪϵͳÓÐÒ»¶¨µÄ±£»¤×÷Óá£
¼ÈȻѡÔñÁË£¬¾Í¼á³ÖÏÂÈ¥£¡
2Â¥2013-11-06 11:42:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

befair

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
hanches: ½ð±Ò+2, Ç×µÄÓ¦ÖúÒ»Ö±Õâô¸øÁ¦£¬BB½±Àø~~~ 2013-11-06 13:48:43
fanjiaojiao: ½ð±Ò+20, ¡ï¡ï¡ïºÜÓаïÖú, лл 2013-11-06 14:13:39
fanjiaojiao: ½ð±Ò+5, ¡ï¡ï¡ïºÜÓаïÖú, ÔٴθÐл Ç×µÄÈÈÐÄÓ¦Öú£¬Ð»Ð»ÁË~~ 2013-11-06 14:16:53
Â¥Ö÷µÄÓ¢ÎÄÒѾ­ºÜ²»´íÁË£¬²»¹ý¼ÈȻ¥Ö÷˵ҪÈóÉ«£¬ÔÚϾͲ»±Ü´µÃ«Çó´ÃÖ®ÏÓÁË£¬Ò»µãС½¨Ò鹩²Î¿¼ (¸ÄÁ˵ÄÓôóд£©¡£
1. Results Compared with THOSE OF the control group£¬the number of peripheral white blood cell£¨WBC£©£¬red blood cell£¨RBC£©£¬hemoglobin£¨HGB£©£¬lymphocyte£¨LYMF£©and granulocyte£¨GRAN£©of THE model group ALL decreased significantly (P < 0.05 or P < 0.01).
2. Â¥Ö÷ÓÃÁ˼¸´Î decreased significantly »òÕß increased significantly¡£ÎªÁËÎÄÕ¸ü¼ÓÃ÷È·£¬¿É·ñ¿¼ÂǸø³ö´ó¸ÅµÄ±ä»¯ÄØ£¨Èçfrom 15% to 30%»òÕß·´¹ýÀ´)£¬»òÕß»»¸ö±í´ï·½Ê½
3. ÔÚÎÄÖÐÌáµ½µÄ¼¸¸ögroup,ËÆºõ²»ÊǺÜÇå³þ£¬µ«ÔÚÏÂÊÇÍâÐУ¬£ºcontrol group, model group, drug-treated groups, group of rhG-CSF, Zhengyuan Prescription medium dose group. ¿É·ñ³ÎÇåÏ£¿
4. ¡£¡£¡£lung AND kidney
5. Conclusions Ò»°ãÓø´Êý
Befairorbeaware
3Â¥2013-11-06 13:27:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zyllucky

½ð³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
hanches: ½ð±Ò+2, ¸ÐлӦÖú£¬BB½±Àø£¬»¶Ó­³£À´±¾°æ²ÎÓë½»Á÷~~~ 2013-11-06 13:49:16
fanjiaojiao: ½ð±Ò+20, ¡ï¡ï¡ïºÜÓаïÖú, лл 2013-11-06 14:14:03
ÎÒÊÇÍâÐУ¬´ó¸Å¸ÄÁËһϡ£Â¥Ö÷Ò»¶¨×¢ÒâÖÐÎıêµã·ûºÅºÍÓ¢Îıêµã·ûºÅµÄÇø±ð£¬Â¥Ö÷Ó¢ÎÄÀï´ó²¿·Ö·ûºÅ¶¼ÊÇÖÐÎıêµã·ûºÅ¡£
Results
Compared to the guinea pigs from control group, the number of peripheral white blood cell (WBC), red blood cell (RBC), hemoglobin (HGB), lymphocyte (LYMF) and granulocyte (GRAN) decreased significantly (P < 0.05 or P < 0.01) in those from model group. Varying degrees of damage were also observed in megakaryocyte cells of model group by bone marrow smears. Compared to the guinea pigs from this model group, the number of peripheral WBC increased significantly (P < 0.01) in guinea pigs from drug-treated groups, among which the most significant increases were observed for WBC and GRAN in rhG-CSF-treated ones (P < 0.01). As far as medium-dose Zhengyuan-treated guinea pigs are concerned, the numbers of WBC, RBC, HGB, LYMF and GRAN are all remarkably increased (P < 0.01 or P < 0.05), while no significant changes were observed for the organ indexes of heart, liver, spleen, lung and kidney (P > 0.05). Revealed by bone marrow smear, medium-dose Zhengyuan has the best therapeutic effect in all drugs tested on bone marrow nucleated cells and megakaryocytic cells suppressed by CTX.
Conclusion
Zhengyuan promotes the recovery of peripheral blood and the regeneration of bone marrow cells of guinea pigs induced by CTX, and thus has a protective effect on the bone marrow hematopoietic system.
ºýÍ¿Ïɶù
4Â¥2013-11-06 13:46:24
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zyllucky

½ð³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
fanjiaojiao: ½ð±Ò+5, ¡ïÓаïÖú 2013-11-06 14:14:12
²»ºÃÒâ˼£¬µÚÁùÐÐare all remarkably increased ÖУ¬areҪȥµô
ºýÍ¿Ïɶù
5Â¥2013-11-06 13:52:48
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÈýÏæËÄË®

гæ (³õÈëÎÄ̳)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
fanjiaojiao: ½ð±Ò+10, ¡ïÓаïÖú, лл£¬ 2013-11-07 10:11:45
¿´µÃ³öÀ´Â¥Ö÷ÊÇÓÃCTXÔìÄ£×öʵÑéµÄ¡£ÖÐÎıí´ï»¹ËãÇå³þ£¬µ«Ó¢Îıí´ï¾ÍÓÐÎÊÌâÁË¡£ÄãÓ¢ÎÄʵ¼ÊÏë˵µÄÊÇCTXÔìÄ£¶¯ÎïºÍûʹÓÃCTXµÄƽ³£¶¯ÎïÖ®¼äÊÇÓвîÒìµÄ£¬Í¨³£Ó¢ÎÄÊÇÒÔ¡°naive animal"±íʾδ×÷Èκδ¦ÀíµÄ¶¯ÎÒÔ¡°¡­¡­treated animal¡±À´Ã÷È·µÄ±í´ïÓëδ´¦Àí¶¯Îï¼ä±È½Ï£¬¶ø²»Óá°Model animal¡±£¨ÕâÊÇÊÜÖÐÎÄ¡°ÔìÄ£¶¯ÎӰÏìµÄºÛ¼££¬ÔÚÄãÕâÆª¶ÌÎÄÖУ¬ÕâÀàºÛ¼£²»ÉÙ£©¡£ÊéдӢÎĵÄרҵÎÄÕÂ×î¼É»äµÄÊÇ¡°ÎÞÌØ¶¨ÐÔ¡±£¬ÄÇÑùµÄ»°Ê¹ÈË¿´Á˳ÔÁ¦ºÍ·Ñ½â£¬²»ÄÜһĿÁËÈ»¡£Í¨³£Ó¢ÎÄרҵÎÄÕÂÓï·¨¡¢µ¥´Ê£¨¶ÔרҵÈËÊ¿¶øÑÔ£©¶¼²»ÊÇʲôÄÑÌ⣬¹Ø¼üÊÇ·ûºÏרҵ±í´ïϰ¹ß£¬·ñÔò½»Á÷ÆðÀ´¾ÍºÜ³ÔÁ¦¡£È˼ҿÉÒÔ¶®ÄãµÄÓ¢ÎÄ£¬µ«²»¶®ÄãÏë˵ɶ¡£¹©Äú²Î¿¼¡£
6Â¥2013-11-07 10:06:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ fanjiaojiao µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 070300»¯Ñ§Ñ§Ë¶Çóµ÷¼Á +6 Ì«Ïë½ø²½ÁË0608 2026-03-16 6/300 2026-03-16 16:13 by kykm678
[¿¼ÑÐ] ±¾ÈË¿¼085602 »¯Ñ§¹¤³Ì ר˶ +11 ²»ÖªµÀ½Ðʲô£¡ 2026-03-15 13/650 2026-03-16 15:10 by ÁËÁËÁËÁË¡£¡£
[¿¼ÑÐ] 312Çóµ÷¼Á +3 İå·Ï£ 2026-03-16 4/200 2026-03-16 15:06 by peike
[¿¼ÑÐ] 326Çóµ÷¼Á +3 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 3/150 2026-03-16 13:51 by houyaoxu
[¿¼ÑÐ] 0854¿ØÖƹ¤³Ì 359Çóµ÷¼Á ¿É¿çרҵ +3 626776879 2026-03-14 8/400 2026-03-16 13:42 by Dream007008
[¿¼²©] ¶«»ªÀí¹¤´óѧ»¯²Äרҵ26½ì˶ʿ²©Ê¿ÉêÇë +6 zlingli 2026-03-13 6/300 2026-03-15 20:00 by ryzcf
[¿¼ÑÐ] Çóµ÷¼Á£¡ +4 Ë·Ë·»° 2026-03-09 4/200 2026-03-14 01:38 by JourneyLucky
[¿¼ÑÐ] 265Çóµ÷¼Á +9 Сľ³æ085600 2026-03-09 12/600 2026-03-14 01:11 by JourneyLucky
[¿¼ÑÐ] 327Çóµ÷¼Á +4 Ffff03 2026-03-10 4/200 2026-03-14 00:17 by JourneyLucky
[¿¼ÑÐ] 279Çóµ÷¼Á +3 ×¥×ÅÐÇÐǵÄÅ®º¢ 2026-03-10 3/150 2026-03-13 23:47 by userper
[¿¼ÑÐ] 0703£¬333·ÖÇóµ÷¼Á Ò»Ö¾Ô¸Ö£ÖÝ´óѧ-ÎïÀí»¯Ñ§ +3 Àîħٶ·Åñ 2026-03-11 3/150 2026-03-13 22:24 by JourneyLucky
[¿¼ÑÐ] 333Çóµ÷¼Á +3 ÇòÇò¹ÅÁ¦ 2026-03-11 3/150 2026-03-13 21:27 by JourneyLucky
[ÂÛÎÄͶ¸å] Ͷ¸åÎÊÌâ 5+4 Ðǹâ²ÓÀÃxt 2026-03-12 6/300 2026-03-13 14:17 by god_tian
[¿¼ÑÐ] 0817»¯Ñ§¹¤³ÌÓë¼¼Êõ¿¼ÑÐ312·Öµ÷¼Á +3 T123 tt 2026-03-12 3/150 2026-03-13 10:49 by houyaoxu
[¿¼ÑÐ] 274Çóµ÷¼Á0856²ÄÁÏ»¯¹¤ +12 z2839474511 2026-03-11 13/650 2026-03-13 10:39 by peike
[¿¼ÑÐ] »¯¹¤Ñ§Ë¶306Çóµ÷¼Á +9 42838695 2026-03-12 9/450 2026-03-13 10:16 by houyaoxu
[¿¼ÑÐ] 420Çóµ÷¼Á +4 ĪÏòÍâÇó11 2026-03-10 6/300 2026-03-12 14:41 by ruiyingmiao
[¿¼²©] ¶Á²©ÉêÇë +5 ¸Ðdd 2026-03-10 7/350 2026-03-11 17:02 by QGZDSYS
[¿¼ÑÐ] µ÷¼Á +5 ºÇßíŶ»í 2026-03-10 5/250 2026-03-10 22:00 by 28375m
[˶²©¼ÒÔ°] ľ³æºÃÏñ²»ÈÈÄÖÁË£¬ÊDz»ÊÇ£¿ +4 Æ«ÕñƬ 2026-03-10 4/200 2026-03-10 09:51 by longwave
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û